MA30656B1 - Composes organiques - Google Patents

Composes organiques

Info

Publication number
MA30656B1
MA30656B1 MA31654A MA31654A MA30656B1 MA 30656 B1 MA30656 B1 MA 30656B1 MA 31654 A MA31654 A MA 31654A MA 31654 A MA31654 A MA 31654A MA 30656 B1 MA30656 B1 MA 30656B1
Authority
MA
Morocco
Prior art keywords
organic compounds
epothilone
relates
crystalline forms
novel crystalline
Prior art date
Application number
MA31654A
Other languages
English (en)
Inventor
Ernst Kuesters
Michael Mutz
Frank Stowasser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37685905&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA30656(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MA30656B1 publication Critical patent/MA30656B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Composés organiques L'invention se rapporte à de nouvelles formes cristallines d'épothilone B.
MA31654A 2006-08-16 2009-02-20 Composes organiques MA30656B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06119043 2006-08-16

Publications (1)

Publication Number Publication Date
MA30656B1 true MA30656B1 (fr) 2009-08-03

Family

ID=37685905

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31654A MA30656B1 (fr) 2006-08-16 2009-02-20 Composes organiques

Country Status (22)

Country Link
US (1) US8178566B2 (fr)
EP (1) EP2064216A2 (fr)
JP (1) JP2010500387A (fr)
KR (1) KR20090038902A (fr)
CN (1) CN101506217B (fr)
AR (1) AR062375A1 (fr)
AU (1) AU2007286454A1 (fr)
BR (1) BRPI0715963A2 (fr)
CA (1) CA2658475A1 (fr)
CL (1) CL2007002362A1 (fr)
IL (1) IL196558A0 (fr)
MA (1) MA30656B1 (fr)
MX (1) MX2009001635A (fr)
MY (1) MY148355A (fr)
NO (1) NO20091081L (fr)
NZ (1) NZ574194A (fr)
PE (1) PE20081317A1 (fr)
RU (1) RU2009109352A (fr)
TN (1) TN2009000044A1 (fr)
TW (1) TW200815455A (fr)
WO (1) WO2008019820A2 (fr)
ZA (1) ZA200900227B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2927832C (fr) 2010-05-18 2021-03-23 Cerulean Pharma Inc. Conjugues d'agent therapeutique polymere renfermant de la cyclodextrine et leur utilisation
CN103910742B (zh) * 2013-01-07 2016-07-13 浙江海正药业股份有限公司 一种制备埃博霉素b无定形粉末的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20080016756A (ko) 1998-02-05 2008-02-21 노파르티스 아게 유기화합물 함유 조성물
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
UA75365C2 (en) 2000-08-16 2006-04-17 Bristol Myers Squibb Co Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon
GB0029895D0 (en) 2000-12-07 2001-01-24 Novartis Ag Organic compounds
HRP20050278A2 (en) * 2002-09-23 2005-10-31 Bristol-Myers Squibb Company Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b

Also Published As

Publication number Publication date
KR20090038902A (ko) 2009-04-21
TW200815455A (en) 2008-04-01
CL2007002362A1 (es) 2008-08-08
WO2008019820A3 (fr) 2008-04-17
JP2010500387A (ja) 2010-01-07
US8178566B2 (en) 2012-05-15
NZ574194A (en) 2011-12-22
CN101506217B (zh) 2012-09-05
CN101506217A (zh) 2009-08-12
MY148355A (en) 2013-03-29
MX2009001635A (es) 2009-02-23
TN2009000044A1 (en) 2010-08-19
IL196558A0 (en) 2009-11-18
AR062375A1 (es) 2008-11-05
NO20091081L (no) 2009-03-16
ZA200900227B (en) 2009-12-30
WO2008019820A2 (fr) 2008-02-21
AU2007286454A1 (en) 2008-02-21
US20100160393A1 (en) 2010-06-24
RU2009109352A (ru) 2010-09-27
PE20081317A1 (es) 2008-10-28
BRPI0715963A2 (pt) 2013-08-06
CA2658475A1 (fr) 2008-02-21
EP2064216A2 (fr) 2009-06-03

Similar Documents

Publication Publication Date Title
CR20140316A (es) Derivados de indol como antagonistas receptores de s1p1 (divisional 10922)
CR8475A (es) Fenilalanina-amidas sustituidas por benzoilo
BRPI0812632A2 (pt) de compostos de efluente aquoso"
UY29927A1 (es) Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones
EP1888534A4 (fr) Composes organiques
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
EP2023729A4 (fr) Composés organiques
EP2081431A4 (fr) Composés organiques
ES2338590T3 (es) Procedimiento regioselectivo de preparacion de benzoimidazoltiofenos.
EP2013701A4 (fr) Désambiguïsation d'entités nommées
MA28490B1 (fr) Formulations galeniques de composes organiques
BRPI0813341A2 (pt) " uso de compostos, composições curáveis, e, uso de composições curáveis ".
NO20071476L (no) Antidiuretiske midler.
EP1939202A4 (fr) Nouveau composé de l'adénine
GT200500101A (es) Compuestos de metil-aril o heteroaril-amida sustituida
MA32369B1 (fr) Composes de benzene sulfonamide thiazole et oxazole
CY1109911T1 (el) Πυρρολοβενζοδιαζεπινες
WO2007084595A3 (fr) Benzènesulfonyle-chromane, thiochromane, tétrahydronaphthalène et inhibiteurs de la gamma secrétase associés
EP2094118A4 (fr) Composition amelioree d'acide peracetique
EA200970102A1 (ru) Короткоцепочечный разветвленный полипропилен
EP2129224A4 (fr) Composés de 5,6-dihydro-1h-pyridine-2-un
ECSP088623A (es) Derivados de azepinoindol como agentes farmacéuticos
EP1746141A4 (fr) Composition d' epaississement
MX2009003713A (es) Inhibidor de progresion de enfermedad de alzheimer que contiene un compuesto heterociclico con estructura especifica.
GT200500296A (es) Sintesis asimetrica de derivados del dehidrobenzofurano